Cargando…
Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report
BACKGROUND: The detection of microsatellite instability in urologic cancers is rare, especially in metastatic, castration-resistant prostate cancer with neuroendocrine differentiation. CASE PRESENTATION: This is a case of a 66-year-old Asian male patient with prostate adenocarcinoma who had metastas...
Autores principales: | Yoshida, Tsukasa, Yaegashi, Hiroshi, Toriumi, Ren, Kadomoto, Suguru, Iwamoto, Hiroaki, Izumi, Kouji, Kadono, Yoshifumi, Ikeda, Hiroko, Mizokami, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523122/ https://www.ncbi.nlm.nih.gov/pubmed/36185251 http://dx.doi.org/10.3389/fonc.2022.912490 |
Ejemplares similares
-
Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review
por: Kadomoto, Suguru, et al.
Publicado: (2020) -
Decreased febrile neutropenia during inpatient chemotherapy for urologic cancer during coronavirus disease 2019 pandemic
por: Toriumi, Ren, et al.
Publicado: (2022) -
Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer
por: Iwamoto, Hiroaki, et al.
Publicado: (2022) -
Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma
por: Makino, Tomoyuki, et al.
Publicado: (2023) -
A novel screening strategy for clinically significant prostate cancer in elderly men over 75 years of age
por: Iwamoto, Hiroaki, et al.
Publicado: (2020)